Skip to main content
Watch Insiders
Market intelligence
ARWRHealthcare

Arrowhead Pharmaceuticals Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 12, 2026Hongbo LuCorporate insiderSale2,970$76.88$228,334
Apr 23, 2026James C HamiltonChief Medical OfficerSale10,000$75.00$750,000
Apr 22, 2026Daniel Joseph ApelChief Financial OfficerSale13,095$71.35$934,285